Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-16

Clinical Trial Update: Gracie Diet for Gastroesophageal Reflux Disease [NA]

View source ↗

Summary

Johns Hopkins University is conducting a study on the Gracie Diet for gastroesophageal reflux disease (GERD); the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: Gastroesophageal Reflux, GERD | NA | Status: ACTIVE_NOT_RECRUITING